NF-115
NF-115 is a glycolipid and Neurostatin analog. NF-115 inhibits the expression of the ARHGDIA gene and alters the biosynthetic pathway of glycosphingolipids. NF-115 induces Apoptosis. NF-115 exhibits anticancer activity against glioma. NF-115 can be used in research related to glioma, glioblastoma and neuroectodermal tumors.
For research use only. We do not sell to patients.
- CAS No.: 368870-53-5
- Formula: C21H41NO9
- Molecular Weight:451.56
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
NF-115 (43 µM) inhibits the proliferation of human U-373 glioma cells (ID50 = 43 μM)[1].
NF-115 (180 μM) inhibits proliferation of U373-MG human astrocytoma cells with an ID50 of 180 μM[3].
NF-115 alters gene expression in U373-MG human glioblastoma cells, repressing 491 genes and up-regulating 76 genes, including specific repression of ARHGDIA, SLC4A2, YWHAE, TP53, and BCL2L1 with fold changes ranging from -0.3 to -0.7 relative to untreated controls[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human U373-MG and T98G astrocytoma cell lines
-
Concentration:250–500 μM
-
Incubation Time:24 h
-
Result:Inhibited the proliferation of U373-MG and T98G astrocytoma cell lines.
In Vivo
NF-115 disrupts astrocytomas implanted in immunodeficient mice[2].
NF-115 disrupts neuroectodermal tumors implanted in rats[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:not specified strain[1]
-
Dosage:NF-115 loaded on slow-delivery polymer disc
-
Administration:intratumoural; daily; 15 days
-
Result:Caused a progressive decrease in tumour volume until total disappearance in treated rats
Chemical Information
-
CAS No. 368870-53-5
-
Molecular Weight 451.56
-
Formula C21H41NO9
-
SMILES
O(CCCCCCCC)[C@@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](COCC(CO)(CO)CO)O1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
[1]. Nieto-Sampedro M, et al. Natural, synthetic and semisynthetic glycolipid inhibitors of glioma growth. Expert Opin Ther Pat. 2004;14(4):487-497. [Content Brief]
[2]. Nieto-Sampedro M, et al. Natural, synthetic and semisynthetic glycolipid inhibitors of glioma growth. Expert Opin Ther Pat. 2004 Apr;14(4):487-97. [Content Brief]
[3]. Doncel-Pérez E, et al. Synthetic glycolipids for glioma growth inhibition developed from neurostatin and NF115 compound. Bioorg Med Chem Lett. 2013 Jan 15;23(2):435-9. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)